SCHEMBL19523880

SCHEMBL19523880

COc1ccc(BO)cc1Cl

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 2/20 0.43
▸ KMT2A Q03164 4/20 0.42
▸ MEN1 O00255 3/20 0.42
▸ ALDH1A1 P00352 5/20 0.41
▸ MAPT P10636 3/20 0.41
▸ SMN1; SMN2 Q16637 5/20 0.41
▸ TP53 P04637 1/20 0.41
▸ PKM P14618 1/20 0.41
▸ HPGD P15428 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ RAB9A P51151 2/20 0.40
▸ ALOX15 P16050 1/20 0.40
▸ HSD17B10 Q99714 1/20 0.40
▸ GLA P06280 1/20 0.40
▸ GAA P10253 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ POLB P06746 2/20 0.39
▸ TTR P02766 1/20 0.39
▸ ACHE P22303 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8288344 0.81 CA2 (0.48) KMT2AMEN1ALDH1A1HPGDHSD17B10
SCHEMBL14273283 0.79 CSNK2A1 (0.51) KMT2AMEN1SMN1; SMN2HPGDGLA
SCHEMBL26447172 0.76 RAB9A (0.50) HTTKMT2AMEN1ALDH1A1SMN1; SMN2
SCHEMBL2093081 0.74 GAA (0.45) HTTKMT2AMEN1ALDH1A1MAPT
SCHEMBL8042030 0.73 HSD17B10 (0.46) ALDH1A1TP53HSD17B10GAATTR
SCHEMBL14551877 0.73 CA12 (0.41) HTTKMT2AMEN1ALDH1A1MAPT
SCHEMBL14201716 0.73 ALDH1A1 (0.52) ALDH1A1HPGD
SCHEMBL2096187 0.72 MAOB (0.56) KMT2AMEN1ALDH1A1MAPTSMN1; SMN2
SCHEMBL2489812 0.72 CYP3A4 (0.46) HTTKMT2AMEN1MAPTSMN1; SMN2
SCHEMBL1138419 0.72 SMN1; SMN2 (0.52) HTTKMT2AMEN1ALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3611174-A1 [1,2,4]TRIAZOLO[1,5-C]PYRIMIDINE DERIVATIVE AS A2A RECEPTOR INHIBITOR Medshine Discovery Inc. (CN) 2020-02-19 — — EP disclosed
EP-3013823-B1 IMIDAZOLE COMPOUNDS AS MODULATORS OF FSHR AND USES THEREOF MERCK PATENT GMBH (DE) 2017-11-01 — — EP disclosed
CN-1972695-A Treatment or prevention of skin conditions or tissue conditions in animals using boryloxypyridylmethanones ANACOR PHARMACEUTICALS INC (US) 2007-05-30 — — CN disclosed
Send feedback